Combination therapy and switching between CGRP antibodies: New frontiers in the management of refractory migraine?
According to recent guidelines, refractory migraine is defined by failure to respond to all the available preventive treatments and experiencing at least eight debilitating headache days per month for at least six consecutive months.1 In these cases, the combined use of preventive treatments is recommended.1 As part of the educational topical symposium on CGRP and migraine
Login to register to read this article
If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.
Log InNot registered yet? Register now